2002

Nov 15, 2002
Guidant to Highlight New Advances in Heart Failure Management During 75th Scientific Sessions of the American Heart Association

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it is providing support for a special Continuing...

Nov 15, 2002
Guidant Appoints Joseph M. Smith, M.D., Ph.D. as Chief Medical Officer for Cardiac Rhythm Management

Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that Joseph M. Smith, M.D., Ph.D....

Nov 14, 2002
New National Registry Will Study Left Ventricular Dysfunction in 100,000 Patients

Scientific data-gathering effort will provide meaningful information on a cardiac condition that precedes or accompanies serious heart disease such as heart failure Indianapolis, Ind. and St....

Nov 13, 2002
Guidant and Genzyme Announce Cross-License Agreement

Deal Demonstrates Guidant's Commitment to Innovation and Intellectual Property Indianapolis, Ind. and Cambridge, Mass. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...

Nov 13, 2002
Guidant to Participate in the Credit Suisse First Boston Health Care Conference

Live Webcast Available Indianapolis, Ind - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will participate in the...

Nov 8, 2002
Guidant to Host Mid-Quarter Investor Briefing

Live Webcast Available Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will host a...

Oct 30, 2002
Guidant Offers Award-Winning Women's Health Care Physician Education Program

Program Designed to Improve Prevention, Diagnosis and Treatment of Cardiovascular Disease in Women Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...

Oct 25, 2002
Guidant Announces First Implants of Next Generation Heart Failure Technology

Live Broadcast of Implants Allows Physicians to Participate in Unique Training Opportunity Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the...

Oct 24, 2002
Guidant Submits Application for FDA Approval of MULTI-LINK VISION Cobalt Chromium Coronary Stent

Stent System Incorporates Innovative Material for Excellent Performance Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...

Oct 17, 2002
Guidant Reports All-Time Record Sales and Third Quarter Earnings

Quarterly Sales grew 25 percent to $827 million with Net Income of $175 million (+43 percent) and Earnings Per Share of $0.57 (+42 percent) Double-digit sales and earnings growth projected for...

Oct 11, 2002
Guidant Receives FDA Approval for its Next Generation Heart Failure Technology

Small, Physiologic-shaped CONTAK CD 2 System Combines Treatment for Both Heart Failure and Sudden Cardiac Death Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and PCX: GDT), a...

Oct 9, 2002
Guidant Announces Live Webcast of its Third Quarter Earnings Conference Call

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, will conduct a live webcast of its third quarter 2002 earnings...

Oct 3, 2002
Guidant Receives Humanitarian Device Exemption for New Intracranial Stent

NEUROLINK Stent May Provide Hope for Patients at High Risk for Recurrent Stroke Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment...

Oct 2, 2002
Guidant Comments on Cook-Boston Scientific Litigation

Conference Call/Webcast Scheduled at 11AM EDT Today Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT) reported that the United States District Court for the Northern District of...

Oct 1, 2002
Guidant Announces European Market Launch of Next-Generation Implantable Defibrillators

World''s smallest, thinnest defibrillator offers advanced rhythm discrimination and industry-leading longevity Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and PCX: GDT), a...

Oct 1, 2002
Guidant Announces FDA Clearance and Worldwide Launch of New Product for Treating Peripheral Vascular Disease

High-Performance, Low-Profile System Offers Physicians New Option Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac...

Sep 30, 2002
Guidant Announces Preliminary Results of Largest Drug Eluting Stent Trial To Date

Early Data from 1,533-Patient Trial Supports Safety of Paclitaxel Eluting Stents In High-Risk Patients Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment...

Sep 27, 2002
Guidant Announces Results of Key Study In Emerging Field of Heart Attack Prevention

Vulnerable Plaque Presents Significant Opportunity for Preventive Therapy Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular...

Sep 25, 2002
Guidant Commends New Guideline for Defibrillator Implants

New Guideline Reflects Results of MADIT II Trial Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease,...

Sep 24, 2002
Guidant Launches Next-Generation Radiotherapy System in the United States

System Designed to Enable Physicians to Treat Long Vessel Blockages With Ease and Precision Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in...

Sep 23, 2002
Guidant to Sponsor Symposium on the Diagnosis and Treatment of Women with Heart Disease at TCT Conference

Session to Improve Knowledge and Practices to Help Overcome Rising Mortality Rate Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and...

Sep 23, 2002
Guidant Introduces Innovative New Device for Coronary Bypass Graft Procedures

New Technology May Reduce Risk of Major Complications Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular...

Sep 17, 2002
Guidant Becomes Exclusive Licensee of Everolimus for Drug Eluting Stents

Guidant Expands Agreement with Novartis Pharma AG Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, announced today...

Sep 17, 2002
Guidant Updates Investors During Annual Investor/Analyst Conference in New York

Company Reiterates Guidance for 2002; Previews 2003 Full-Year Revenue and Earnings Per Share New York - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and...

Sep 16, 2002
Guidant Launches Newest Coronary Stent in the United States

Sixth-Generation MULTI-LINK Stent System Features Enhanced Deliverability, Market-Leading Stent Design Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world...

Show per page

Top